Monroe Capital Corporation (MRCC)
NASDAQ: MRCC · Real-Time Price · USD
7.20
-0.10 (-1.44%)
Apr 25, 2025, 2:34 PM EDT - Market open
Company Description
Monroe Capital Corporation is a business development company specializing in customized financing solutions in senior, unitranche and junior secured debt, subordinated debt financing and to a lesser extent, unsecured debt and equity, including equity co-investments in preferred and common stock and warrants.
It also provides financing primarily to leveraged buyouts in lower middle-market companies. It focuses to invest in the United States and Canada.
The fund prefers to invest in companies with EBITDA between $3 and $35 million. Its makes minority equity investments.
Monroe Capital Corporation
Country | United States |
Founded | 2011 |
IPO Date | Oct 25, 2012 |
Industry | Asset Management |
Sector | Financials |
CEO | Theodore Koenig |
Contact Details
Address: 311 South Wacker Drive, 64th Floor Chicago, Illinois 60606-6710 United States | |
Phone | 312 258 8300 |
Website | monroebdc.com |
Stock Details
Ticker Symbol | MRCC |
Exchange | NASDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001512931 |
CUSIP Number | 610335101 |
ISIN Number | US6103351010 |
Employer ID | 27-4895840 |
Key Executives
Name | Position |
---|---|
Lewis W. Solimene Jr. | Chief Financial Officer, Chief Investment Officer and Secretary |
Aakash Bhansali | Chief Accounting Officer |
Kristan Renee Gregory | Chief Compliance Officer |
Kenneth Fahrman | MD and Head of North America, Business Development and Institutional Funds |
Alicia Costello | Head of Fundraising Management and Project Management |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 24, 2025 | ARS | Filing |
Apr 24, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Apr 21, 2025 | DEF 14A | Other definitive proxy statements |
Apr 18, 2025 | 8-K | Current Report |
Apr 8, 2025 | PRE 14A | Other preliminary proxy statements |
Apr 4, 2025 | APP WD | Filing |
Apr 4, 2025 | 40-APP | Filing |
Mar 31, 2025 | 8-K | Current Report |
Mar 3, 2025 | 8-K | Current Report |
Feb 28, 2025 | 10-K | Annual Report |